Here is a map of all the cannabis stores in Texas 2024

Here is a map of all the cannabis stores in Texas 2024

In recent years, Texas has experienced a profound transformation in its stance towards medical cannabis. Once notorious for its stringent regulations on cannabis, the Lone Star State has now embraced the legal medical use of cannabis. This article serves as your guide to see a map and navigate the ever-evolving cannabis landscape in Texas in 2024.

 

The Legal Framework:

Texas Compassionate Use Program was enacted by the 84th legislative session with Senate Bill 339 which was led by Rep. Stephanie Klick among many others to develop a registry of physicians to treat epilepsy with low THC medical cannabis (less than 1%), this registry is called Compassionate Use Registry of Texas or sometime referred to as CURT and is managed by the Department of Public Safety (DPS).

Market Growth

The program began to grow with the issuance of licenses in 2017 to 3 organizations who through substantial vetting became the 3 licensed operators. In 2019 a brief window to apply became available where dozens of companies applied though no additional licenses were issued. The rationale of no new licenses was due to the requirement that the department issue at least three licenses but no more than the number of licenses necessary to ensure reasonable statewide access to, and availability for patients prescribed low-THC cannabis, referring to Texas Health and Safety Code Chapter 487 & Chapter 169, Occupations Code. These licenses pay a biennial renewal fee to maintain their license costing $318,511 every 2 years with an additional $530 registration fee for each occurrence. This comes after the initial $488,520 first two year license fee.

Though the stakes seem high for operators in a limited market that hasn’t grown since 2017 by supply of licenses, the demand has continued to grow throughout the years the program has operated by expanding medical conditions and patients who have exponentially registered. Conditions starting from epilepsy have increased to include Amyotrophic lateral sclerosis, Autism, Cancer, Epilepsy, Incurable neurodegenerative disease (Parkinson’s, MS, etc), Multiple sclerosis, Post-traumatic stress disorder, Seizure disorder, Spasticity, or Medical conditions designated by the Health and Human Services Commission as authorizing treatment with low-THC cannabis as part of an approved research program. In a recent 2023 session an effort to add Chronic Pain to the list to expand the program was voted down in the Texas state senate.

Through the years the patient registry data provided by DPS and illustrated by TexMedCannabis.com show patients have grown from 4 patients in November of 2017, to increase each year to 646 (2018), 1,187 (2019), 3,519 (2020), 14,926 (2021), 41,216 (2022), 70,835 (2023). In parallel the number of registered physicians has also increased from 8 in November of 2017 to 55 (2018), 143 (2019), 240 (2020), 489 (2021), 657 (2022), 772 (2023). Patients to get their medical card tend to spend hundreds of dollars annually while also having inflated priced cannabis medication.

 

Types of Cannabis Shops

Texas currently offers a limited variety of medical cannabis shop types, specifically accessible through in person dispensary (3), pick up location (dozens), or delivery to doorstep to cater to different consumer preferences and needs. Understanding the nuances of these establishments can significantly impact your cannabis shopping experience.

Dispensaries, delivery services, and pick up locations each provide distinct advantages and disadvantages. Dispensaries offer an in-person shopping experience with expert guidance, while delivery services provide convenience, and pick up locations land somewhere in the middle. Co-ops and lounges are not offered for social consumption. Knowing the differences between these options is essential for consumers to make informed choices.

 

Texas Medical Cannabis Providers

Goodblend Texas

A multi-state operateor (MSO) also known as Paralell
(https://tx.goodblend.com/)

Texas_YesTexas_Goodblend

 

 

Texas CUP License #0006 – issued Dec. 15, 2017

Austin, TX

Texas Original

A single-state operator (SSO) known as the local Texas organization
(https://texasoriginal.com/)

YesTexas_TexaslOriginal

 

 

 

 

Texas CUP License #0005 – issued Oct. 31, 2017

Manchaca, TX

Fluent

A multi-state operateor (MSO) also known as Cansortium
(https://texas.getfluent.com/)

TexasYes_Fluent

 

Texas CUP License #0004 – issued Sept. 1, 2017

Schulenburg, TX

 

Current Notable Medical Cannabis Brands & Products

Medical cannabis products are currently limited in the Texas market. These vertical operators have focused on owned and operated products that all use extraction methods, i.e. no smokable products in the state. Some existing products do have recognition for their quality and ratio varieties.

Edibles and Tincture: Surterra Wellness aka Goodblend Texas (https://tx.goodblend.com/shop)
Tincture: Fluent (https://texas.getfluent.com/shop/)
Tincture: Texas Original (https://texasoriginal.com/shop)
Topical: Surterra Wellness aka Goodblend Texas (https://tx.goodblend.com/shop)

The Texas cannabis landscape is an early one, characterized by trends in potential for product innovation, potency adjustment, and evolving consumer needs based on medical use case. Staying informed about these trends and discussing with their physician will allow consumers to discover products that align with what’s on shelves.

 

Geographic Distribution

The distribution of medical cannabis shops in Texas is far from uniform or with widely available access. A map showcasing the geographic distribution of these shops reveals the extent of the industry’s presence across the state.

Major cities like Houston, Dallas, and Austin boast a higher concentration of cannabis shops compared to rural areas. Many rural areas have little to no access.

Texas Medical Cannabis Locations

Goodblend (Blue) | Texas Original (Green) | Fluent (Black)

 

Hemp Market Relevance

The Texas hemp market is a strong and growing market full of numerous products that meet the federal requirement of being below .03% THC per package. Throughout Texas and many nearby states, liquor stores, smoke shops, cbd stores, and other types of establishments are widely selling and distributing hemp products.

This less regulated program has a lower barrier to entry and consists of operators who lean into the looser definition of the federal hemp bill. Operators in this case could utilize psychoactive non-THC cannabinoids such as Delta-8 in balance with THCa and other cannabinoid varieties and use regular forms of delivery to reach a wider array of consumers. When formulating products by volume it is possible to provide products that could offer the same or similar benefit, potency, and quality to that of the 1% THC rule in Texas licensed medical cannabis rules.

For patients this presents a potential avenue where access could in theory be easier with lower cost options, though there is a higher risk of product offering due to the less regulated testing standards within the hemp market. We encourage any patients who are trying either hemp or medical cannabis products to consult with their doctor and utilize a measured approach.

2024 will be a big year for cannabis, where both hemp and cannabis see potential change with federal policy and regulations. How will this change or impact the Texas medical cannabis market? It could help bolster or hinder depending on the way regulations move. Staty tuned  for more updates as they come.

EXPLORE MORE NEWS

Major Corporations Investing in Cannabis

As cannabis legalization continues to spread across the country, major corporations are increasingly taking notice and investing in the industry. In April of 2023, a major beverage company announced a $100 million investment in a cannabis-infused drink startup, signaling the growing trend of large corporations entering the cannabis space.

A Historic Cannabis Banking Bill Advances to the Senate Floor

In a groundbreaking move, the Senate Banking Committee has approved the Secure and Fair Enforcement Regulation (SAFER) Banking Act, which seeks to bridge the gap between financial institutions and cannabis companies. This legislation, designed to end the cash-only transactions plaguing the industry, is now headed to the Senate floor after years of committee revisions and discussions.

A Green Opportunity: Advertising in the Cannabis Industry

The cannabis industry has undergone a remarkable transformation in recent years, evolving from a taboo, underground market to a legitimate, booming industry. As legalization continues to spread across the United States and other parts of the world, businesses within the cannabis sector are faced with a unique challenge: how to effectively advertise their products and services in a heavily regulated and stigmatized environment.

Maryland’s First Week of Adult-Use Cannabis Sales Exceeds $20 Million, Fueling Optimism for the Industry’s Growth

In the inaugural week of adult-use sales in Maryland, the combined sales of medical and recreational cannabis products by marijuana retailers reached nearly $21 million. This landmark moment in Maryland’s cannabis industry is the result of a significant historical development—the legalization of recreational cannabis in the state.

Newsletter

Texas Medical Cannabis – Market Statistics Update November 2023 (available on TexMed App – TexMedCannabis.com)

Texas Medical Cannabis – Market Statistics Update November 2023 (available on TexMed App – TexMedCannabis.com)

The Texas Department of Public Safety’s latest data for November 2023 provides an impactful snapshot into the state of Texas medical cannabis landscape. These statistics unveil a perspective on large patient and limited physician growth, as well as the current state of accessibility within the Lone Star State.

Patient Growth:
In November 2023, Texas witnessed an increase in registered patients, reaching a total of 70,835. This marks a notable 3% growth from the previous month, showcasing the state’s sustained momentum in medical cannabis sign ups. Comparing this figure to the same month in the previous year, the patient count has surged by an impressive 72%, indicating a robust upward trend in demand that has created the hockey stick shape below.

Texas Medical Cannabis Patient Count Nov 2023. TexMed by YesCannabis.

Physician Registration:
The state’s physicians that prescribe medical cannabis has also experienced growth, with 772 registered physicians documented in the latest November data. This represents a steady 1% increase from the previous month, reflecting ongoing engagement and interest among healthcare professionals. Over the past year, the number of registered physicians has seen a substantial 18% growth, indicating positive trends in attracting and retaining medical practitioners.

Texas Medical Cannabis Doctor Count. TexMed by YesCannabis.

Patient-to-Physician Ratio:
The patient-to-physician ratio currently stands at 92 patients per physician. This ratio has grown by 2% from the previous month, underscoring the increased demand for healthcare services. Over the past year, there has been a significant 46% growth in the patient-to-physician ratio, emphasizing the ongoing challenges in healthcare access and the importance of optimizing the distribution of medical resources.

Access to Medical Products:
A striking observation pertains to the limited access to medical products for the 70,835 registered patients. Presently, only three active companies facilitate access, with fewer than 30 locations available for patients who actively participate in the program. This highlights a significant gap in accessibility and emphasizes the pressing need for broader availability and increased options for patients to ensure comprehensive and effective healthcare delivery.

Relative Scale:
In a state as vast as Texas, boasting a population of 30,000,000, the 70,835 registered medical cannabis patients constitute only 0.2% of the total population. This statistic serves as a compelling reminder of the considerable potential for further expansion and development in the state’s medical cannabis program. The relatively low percentage underscores the opportunity to enhance outreach efforts, engage more residents, and address the healthcare needs of a larger portion of the population.

November 2023 data showcases positive trends in patient and physician growth, highlighting the need for ongoing efforts to enhance medical cannabis healthcare infrastructure, accessibility, and the availability of medical cannabis products in Texas.

Comparison with Florida Medical Market

Florida’s Growing Patient Count

At the end of 2022, Marijuana Policy Project (MPP) reported that Florida had 831,775 registered patients, making up 3.74% of the state’s population. This highlights the increasing acceptance of medical cannabis as a viable treatment option.

Extensive Dispensary Network

To cater to this demand, Florida has 501 active dispensaries, operated by 22 different companies, with more on the way. This shows the competitive nature of the industry and ensures patients have convenient access to their prescribed treatments.

Florida’s Medical Cannabis Program is thriving, with a significant patient count and a robust dispensary network, exemplifying the program’s success and the growing role of medical cannabis in the state’s healthcare landscape.

 

News on the latest application round

More than 130 applications have been submitted to the Texas Department of Public Safety for vertically integrated medical marijuana dispensaries, marking a significant response since the reopening of applications in January after a four-year hiatus.

Despite a recent bill to expand the state’s medical marijuana program stalling in the Senate, the DPS reports no current plans for usage law expansion, emphasizing their commitment to ensuring statewide access to low-THC cannabis for registered patients. For further details, visit KVUE.

 

 

Watch the TexMed APP launch video on YouTube

If you’re looking to stay in tune with the Texas Medical market, please check out TexMedCannabis.com

EXPLORE MORE NEWS

Major Corporations Investing in Cannabis

As cannabis legalization continues to spread across the country, major corporations are increasingly taking notice and investing in the industry. In April of 2023, a major beverage company announced a $100 million investment in a cannabis-infused drink startup, signaling the growing trend of large corporations entering the cannabis space.

Proposed Legislation Aims to Address Cannabis Taxation Issues in California

Under the Adult Use of Marijuana Act, the cannabis excise tax in California is currently set at 15% of gross receipts from licensed retail cannabis sales. In addition to this state-level tax, many local governments impose their own additional taxes on cannabis, with some jurisdictions, including Los Angeles, charging as high as 10%.

A Guide to Opening a Cannabis Dispensary in Minnesota

On May 30, 2023 Minnesota Gov. Tim Walz signed an expansive cannabis legalization bill into law, allowing the recreational use of cannabis for adults 21 and older starting Aug. 1. The Legislature passed the bill with a handful of Republicans joining a nearly united Democratic vote in favor. Although the bill has passed, dispensaries can’t open until the state figures out a licensing system for the businesses, so they won’t open for at least another year — some estimate in early 2025. This article aims to provide a detailed guide on how to open a cannabis dispensary in Minnesota. We will explore the current cannabis market and outlook, license types, scoring criteria, application fees, and the importance of seeking professional assistance from cannabis consultants like Global Go.

Cannabis-Infused Cocktails: A Guide to Mixing Cannabis and Spirits

California has long been at the forefront of cannabis legalization and innovation. With the recent legalization of recreational cannabis in the state, a fascinating trend has emerged – the rise of cannabis-infused cocktails. These delightful concoctions, often referred to as “pot-tails” or “weed-tinis,” offer an exciting way to blend the worlds of cannabis and spirits. In this guide, we’ll delve deeper into the world of cannabis-infused cocktails, exploring the methods, safety precautions, and even sharing some mouthwatering recipes for you to try at home.

Newsletter

Texas Medical Cannabis – Market Statistics Update November 2023 (available on TexMed App – TexMedCannabis.com)

Texas Medical Cannabis – Market Statistics Update October 2023 (available on TexMed App – TexMedCannabis.com)

The Texas Department of Public Safety’s latest data for October 2023 provides an intriguing snapshot of the state’s healthcare landscape. These statistics unveil a nuanced perspective on patient and physician growth, as well as the current state of medical accessibility in the Lone Star State.

Patient Growth:
In October 2023, Texas witnessed an increase in registered patients, reaching a total of 68,611. This marks a notable 4% growth from the previous month, showcasing the state’s sustained momentum in healthcare utilization. Comparing this figure to the same month in the previous year, the patient count has surged by an impressive 76%, indicating a robust upward trend in healthcare engagement.

Physician Registration:
The state’s physician roster has also experienced growth, with 765 registered physicians documented in the latest data. This represents a steady 1% increase from the previous month, reflecting ongoing engagement and interest among healthcare professionals. Over the past year, the number of registered physicians has seen a substantial 19% growth, indicating positive trends in attracting and retaining medical practitioners.

Patient-to-Physician Ratio:
The patient-to-physician ratio currently stands at 90 patients per physician. This ratio has grown by 2% from the previous month, underscoring the increased demand for healthcare services. Over the past year, there has been a significant 48% growth in the patient-to-physician ratio, emphasizing the ongoing challenges in healthcare access and the importance of optimizing the distribution of medical resources.

Access to Medical Products:
A striking observation pertains to the limited access to medical products for the 68,611 registered patients. Presently, only three active companies facilitate access, with fewer than 30 locations available for patients who actively participate in the program. This highlights a significant gap in accessibility and emphasizes the pressing need for broader availability and increased options for patients to ensure comprehensive and effective healthcare delivery.

Relative Scale:
In a state as vast as Texas, boasting a population of 30,000,000, the 68,611 registered patients constitute only 0.22% of the total population. This statistic serves as a compelling reminder of the considerable potential for further expansion and development in the state’s medical program. The relatively low percentage underscores the opportunity to enhance outreach efforts, engage more residents, and address the healthcare needs of a larger portion of the population.

October 2023 data showcases positive trends in patient and physician growth, highlighting the need for ongoing efforts to enhance healthcare infrastructure, accessibility, and the availability of medical products in Texas.

Comparison with Florida Medical Market

Florida’s Growing Patient Count

At the end of 2022, Marijuana Policy Project (MPP) reported that Florida had 831,775 registered patients, making up 3.74% of the state’s population. This highlights the increasing acceptance of medical cannabis as a viable treatment option.

Extensive Dispensary Network

To cater to this demand, Florida has 501 active dispensaries, operated by 22 different companies. This shows the competitive nature of the industry and ensures patients have convenient access to their prescribed treatments.

Florida’s Medical Cannabis Program is thriving, with a significant patient count and a robust dispensary network, exemplifying the program’s success and the growing role of medical cannabis in the state’s healthcare landscape.

 

News on the latest application round

More than 130 applications have been submitted to the Texas Department of Public Safety for medical marijuana dispensaries, marking a significant response since the reopening of applications in January after a four-year hiatus.

Despite a recent bill to expand the state’s medical marijuana program stalling in the Senate, the DPS reports no current plans for usage law expansion, emphasizing their commitment to ensuring statewide access to low-THC cannabis for registered patients. For further details, visit KVUE.

 

 

Watch the TexMed APP launch video on YouTube

If you’re looking to stay in tune with the Texas Medical market, please check out TexMedCannabis.com

EXPLORE MORE NEWS

Major Corporations Investing in Cannabis

As cannabis legalization continues to spread across the country, major corporations are increasingly taking notice and investing in the industry. In April of 2023, a major beverage company announced a $100 million investment in a cannabis-infused drink startup, signaling the growing trend of large corporations entering the cannabis space.

Proximity Matters: How Closeness to Cannabis Stores Drives Legal Market Sales in Canada

New research on Canada’s regulated cannabis market has shed light on consumer preferences and their impact on marijuana sales. The study, set to be published in the Journal of Studies on Alcohol and Drugs, explores the relationship between consumers’ proximity to government-regulated cannabis stores and their purchasing decisions.

Missouri Division of Cannabis Regulation Initiates Recall of 62,000 Cannabis Products: An In-Depth Look at the Delta Extraction Case and Industry Lessons

The Missouri Division of Cannabis Regulation (DCR) has recently taken a significant step in the cannabis industry by issuing a recall of more than 62,000 cannabis products manufactured by Delta Extraction, LLC. The reason behind this recall lies in the fact that these products were not being compliantly tracked in the statewide track and trace system known as METRC. This failure to adhere to tracking protocols created a situation where the DCR could not verify the origins of these products – whether they were sourced from marijuana cultivated within Missouri and had undergone the necessary testing procedures.

Alabama Medical Cannabis Commission Makes Second Attempt to Grant Business Licenses

The Alabama Medical Cannabis Commission convened on Thursday for a renewed effort to allocate licenses to companies vying for participation in the state’s burgeoning medical cannabis industry.

Newsletter

Ohio Joins Ranks of Legal Cannabis States as Issue 2 Passes with 57% Voter Approval

Ohio Joins Ranks of Legal Cannabis States as Issue 2 Passes with 57% Voter Approval

In a groundbreaking decision, Ohio has officially become the 24th state to legalize adult-use cannabis. With a resounding 57% of voters supporting the ballot proposal known as Issue 2, this victory marks a significant shift in the landscape of U.S. states where recreational marijuana is legal. This landmark decision paves the way for individuals aged 21 and older to purchase and possess up to 2.5 ounces of cannabis while also permitting home cultivation of up to six plants per person and 12 plants per residence if at least two adults reside there. Furthermore, a 10% tax will be levied on cannabis purchases, with the revenue allocated to cover administrative costs, addiction treatment programs, municipalities with dispensaries, and social equity initiatives and job programs.

The passing of Issue 2 signifies that the United States is just one state away from having adult-use cannabis legalized in half of the states. The National Organization for the Reform of Marijuana Laws (NORML) notes that the legal cannabis movement has already reached a tipping point in terms of population, marking a significant milestone in the ongoing process of loosening cannabis laws in the country. NORML Deputy Director Paul Armentano emphasized, “Today, for the first time since the federal government initiated federal cannabis prohibition in 1937, more people live in a place where marijuana is state-legal than reside somewhere where it isn’t. It borders on political malpractice for elected officials, and for Republican lawmakers especially, to sit on the sidelines at a time when more Americans than ever are demanding action.”

However, it’s worth noting that not all parties were in favor of this progressive change. Republican Governor Mike DeWine voiced his opposition to the measure, and the GOP-led Ohio Senate passed a resolution encouraging voters to reject the initiative, albeit unsuccessfully. Senate President Matt Huffman has expressed his intent to “revisit” provisions of the new law, hinting at possible legislative changes and even a repeal of the adult-use provisions.

Despite these efforts, the outcome of the vote clearly favored those supporting legal cannabis. According to the New York Times election results tracker, 57% of voters approved Issue 2, while only 43% opposed it.

The passage of Issue 2 was not entirely unexpected, as it was driven by the Coalition to Regulate Marijuana Like Alcohol. Prior to the vote, the organization managed to raise more than three times the funding amassed by the opposition group, Protect Ohio Workers and Families.

Businesses across Ohio are now gearing up to embrace the new adult-use cannabis law. NORML predicts that retail cannabis products will be subject to a 10% tax, with anticipated annual tax revenue ranging from $276.2 million to $403.6 million by the fifth year of sales. An additional analysis estimates that the law will create 3,300 new jobs within the first year of legalization.

Various figures within the cannabis industry have expressed their support for this groundbreaking decision in Ohio. Ben Kovler, CEO of Green Thumb Industries, highlighted the historic significance of the vote, saying, “Today marks another historic moment for the cannabis industry and for Ohio, as voters have chosen to end Prohibition 2.0 in the Buckeye State. This vote is not just about legalization; it’s a recognition that Americans are continuing to embrace cannabis for well-being.”

LeafLink, a company operating in 30 markets across the U.S., including Ohio, commended the decision, noting that the legalization of adult-use cannabis in Ohio presents a remarkable opportunity for the state. Rodney Holcombe, LeafLink’s Director of Policy, stated, “This vote presents a tremendous opportunity for the state where legal adult-use sales are projected to exceed $1 billion annually. We have witnessed firsthand the positive impact of legalized cannabis, including job creation, tax revenue for vital government services, and unique business opportunities for entrepreneurs. We urge Ohio officials to promptly enact the law, allowing their constituents to reap these benefits without delay.”

Timeless, a company specializing in concentrates in Ohio, also celebrated the outcome. Joshua Hirschey, President at Timeless Refinery, emphasized the potential economic benefits for the state, stating, “The vote to legalize cannabis in Ohio is a huge win for consumers who have let their voices be heard, as well as a win for the state with the potential to bring in $260M in additional tax revenue, and for operators like Timeless who will be able to serve a wider demographic.”

BDSA, a leading provider of market intelligence for the cannabis industry, expressed its commitment to providing insights for the evolving Ohio cannabis market. Roy Bingham, co-founder and CEO of BDSA, highlighted Ohio’s emerging importance in the cannabis industry, citing the state’s unique regulatory environment and growing acceptance of medical cannabis.

In addition to the legalization of adult-use cannabis, Issue 1, Ohio’s bill designed to protect the right to abortion, was also approved. Provisions in the cannabis law allowing the possession and home cultivation of marijuana by adults will take effect on December 7th, ushering in a new era for cannabis enthusiasts in Ohio.

Source: High Times

EXPLORE MORE NEWS

Major Corporations Investing in Cannabis

As cannabis legalization continues to spread across the country, major corporations are increasingly taking notice and investing in the industry. In April of 2023, a major beverage company announced a $100 million investment in a cannabis-infused drink startup, signaling the growing trend of large corporations entering the cannabis space.

The Importance of Cannabis Testing: Ensuring Safety and Potency

Cannabis, renowned for its medicinal benefits, is now being held to higher standards similar to other medicinal products. As the demand for cannabis continues to grow, regulations and standards are being developed by international organizations to ensure the safety and potency of cannabis products. Cannabis testing labs play a crucial role in this process, aiming to verify the safety of products for human consumption and provide consumers with information about their potency. This article explores the significance of cannabis testing, the substances tested for it, and the importance of understanding potency.

Spotify Breaks Ground with First-Ever Cannabis Ads in Partnership with Cresco Labs

Spotify, the world’s leading music streaming service, has always been known for its bold and innovative approach. In a groundbreaking move, Spotify has become the first streaming platform to embrace cannabis advertising through its new collaboration with Cresco Labs (CRLBF).

Arkansas Medical Cannabis Sales Poised for Record Year with $23.2 Million in July

The trajectory of medical cannabis sales in Arkansas continues to set new records, with transactions in the state soaring to $23.2 million in July. This robust performance propels the total sales of medical marijuana in Arkansas for the initial seven months of 2023 to an impressive $164.6 million. Remarkably, this figure surpasses the corresponding period’s sales from the previous year by a substantial margin of $7.3 million, as reported by Fayetteville TV station KNWA.

Newsletter

Historic Milestone: Georgia Becomes First State to Allow Medical Cannabis Sales in Hundreds of Pharmacies

Historic Milestone: Georgia Becomes First State to Allow Medical Cannabis Sales in Hundreds of Pharmacies

In a groundbreaking development, the Georgia Board of Pharmacy has opened its doors to applications from nearly 120 pharmacies looking to provide medical marijuana products. This historic move makes Georgia the first state in the nation to permit the sale of low-dose cannabis within independent drug stores.

The implementation of the pharmacy rule, which extends medical marijuana sales to drug stores, promises to significantly enhance patient access. Up until now, the state has been served by only seven dispensaries, leaving patients with conditions such as Parkinson’s disease, seizures, terminal cancers, and PTSD with limited options.

The exclusive suppliers for these pharmacies will be the state’s only two licensed cannabis producers: Botanical Sciences LLC and Trulieve Cannabis Corp. These two companies were the first to receive approval earlier this year to cater to registered medical cannabis patients in Georgia.

Gary Long, CEO of Botanical Sciences, expressed his enthusiasm for this development, stating, “Pharmacists have been fielding questions from patients for years without ever having the ability to do anything about it. Finally, they have the ability not just to give people advice but provide them with the therapies they’ve been seeking.”

Georgia boasts more than 400 independent pharmacies, and the majority of them are expected to participate in this program. National chains such as CVS and Walgreens are the notable exceptions, as confirmed by Cecil Cordle, a member of the Georgia Board of Pharmacy.

This initiative is poised to bring convenience to the lives of Georgians, with approximately 90 percent of the state’s population residing within a 30-minute drive of a pharmacy offering medical marijuana products, according to reports.

Andrew Turnage, executive director for the Georgia Access to Medical Cannabis Commission, hailed the pharmacy rule as “definitely big news” and emphasized its benefits for both licensees and, most importantly, patients. He remarked, “It will put access in virtually every county in the state.”

Addressing the number of medical marijuana patients in Georgia, a recent revelation by the Georgia Department of Public Health stirred up some controversy. It was disclosed that the department had miscounted and overstated the count of registered medical marijuana patients. The accurate figure currently stands at just 14,000 active patients and caregivers, a far cry from the previously reported 50,000.

Source: Benzinga

EXPLORE MORE NEWS

Major Corporations Investing in Cannabis

As cannabis legalization continues to spread across the country, major corporations are increasingly taking notice and investing in the industry. In April of 2023, a major beverage company announced a $100 million investment in a cannabis-infused drink startup, signaling the growing trend of large corporations entering the cannabis space.

Texas Medical Cannabis – Market Statistics Update November 2023 (available on TexMed App – TexMedCannabis.com)

The Texas Department of Public Safety’s latest data for September 2023 provides an intriguing snapshot of the state’s healthcare landscape. These statistics unveil a nuanced perspective on patient and physician growth, as well as the current state of medical accessibility in the Lone Star State.

New Jersey Cannabis Regulators Propose New Permits to Facilitate Research Partnerships with Dispensaries

New Jersey’s cannabis regulatory authorities are currently open to public feedback regarding an innovative proposal aimed at introducing a novel permit. This permit would enable “clinically focused” dispensaries to collaborate with research institutions, facilitating comprehensive studies on cannabis using the products they cultivate and sell to patients.

Republican Resistance Blocks Medical Cannabis Legalization Push in North Carolina

Republican resistance has effectively halted the push for medical cannabis legalization in North Carolina. State House Speaker Tim Moore believes that the opposition from Republican lawmakers has doomed the prospects of passing the Compassionate Care Act in 2023. Despite the state Senate’s approval of the bill, which aimed to provide access to smokable flower for patients with 15 qualifying medical conditions in a tightly regulated market, the House took no further action beyond a committee hearing.

Newsletter